Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/26/12 → 12/25/19 |
Funding
- Portola Pharmaceuticals: $10,500.00
Multicenter, Randomized, Active-Contolled Efficacy and Safety Study Comparing Extended Duration Betrixaban With Standard of Care Enoxaparin for the Prevention of Venous Thromboembolism in Acute Medically Ill Patients
- Harris, Linda (PI)
- Cherr, Gregory (CoI)
- Dryjski, Maciej (CoI)
Project: Research